Latest filing published 28 Feb 2018 for Sorrento Therapeutics, Inc..
Insider track record
No signal scores available.
Dean Ferrigno: trading record in brief
Dean Ferrigno discloses dealings in Sorrento Therapeutics, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 11 September 2017 to 28 February 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 28 February 2018 came the latest disclosure, a transaction in Sorrento Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Dean Ferrigno
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 118 sharesCommon StockSEC:0000850261-18-000011:0
- 64 sharesCommon StockSEC:0001144204-17-048348:0
2 of 2 declarations